Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Shares Outstanding (Entity) (2019 - 2025)

Updated

Pharming (PHAR) reported Shares Outstanding (Entity) of 70.17 million for Q4 2025, up 3.1% from 68.03 million a year earlier.

Analysis

Pharming (PHAR) Shares Outstanding (Entity) (2019 - 2025) Analysis & Trends

Dating back to Q4 2019, Pharming's Shares Outstanding (Entity) record includes 7 quarters.

  • Shares Outstanding (Entity) has increased for seven consecutive years, with a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
  • By year, Shares Outstanding (Entity) came in at 68.03 million in FY2024 (+1.4%), 67.11 million in FY2023 (+2.2%), 65.63 million in FY2022 (+1.2%) and 64.87 million in FY2021 (+1.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 941.36 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.41 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.77 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 540.60 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.24 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 5.70 Bn
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 70.17 Mn
Dec 31, 2024 68.03 Mn
Dec 31, 2023 67.11 Mn
Dec 31, 2022 65.63 Mn
Dec 31, 2021 64.87 Mn
Dec 31, 2020 63.88 Mn
Dec 31, 2019 63.13 Mn
API Access

Pharming Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=PHAR&period=max&api_key=YOUR_API_KEY